Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exudative Retinopathy”

123 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 123 results

Not applicableStudy completedNCT00348543
What this trial is testing

Prophylactic Laser Treatment of Drusen Maculopathy

Who this might be right for
Age-related Macular Degeneration
University Hospital, Linkoeping 150
Not applicableUnknownNCT00455871
What this trial is testing

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD

Who this might be right for
Age-Related Macular Degeneration
Barnes Retina Institute 30
Not applicableEnded earlyNCT00474695
What this trial is testing

Study Evaluating Genotypes Using Lucentis

Who this might be right for
Age-Related Maculopathy
University of Utah 65
Early research (Phase 1)Study completedNCT00211419
What this trial is testing

Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Maculopathy, Age-Related
Manhattan Eye, Ear & Throat Hospital
Large-scale testing (Phase 3)Study completedNCT01835067
What this trial is testing

Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD

Who this might be right for
Exudative Macular DegenerationRetinal Hemorrhage
King's College Hospital NHS Trust 55
Not applicableStudy completedNCT05678517
What this trial is testing

Seven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMD

Who this might be right for
Age-Related Macular Degeneration
Semmelweis University 47
Not applicableStudy completedNCT02569892
What this trial is testing

Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration

Who this might be right for
Macular DegenerationRetinal Drusen
Stanford University 19
Post-approval studies (Phase 4)Study completedNCT01810042
What this trial is testing

Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab

Who this might be right for
Exudative Age-related Macular Degeneration
Pusan National University Hospital 49
Large-scale testing (Phase 3)Study completedNCT00321997
What this trial is testing

A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.

Who this might be right for
Age-Related Macular Degeneration
Eyetech Pharmaceuticals 540
Not applicableStudy completedNCT02287298
What this trial is testing

Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

Who this might be right for
Exudative Macular Degeneration
The Retina Center of St. Louis County, PC 400
Large-scale testing (Phase 3)Study completedNCT00051129
What this trial is testing

Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular DegenerationMaculopathy, Age-RelatedAge-Related Maculopathies+2 more
Alcon Research 291
Testing effectiveness (Phase 2)Study completedNCT03669393
What this trial is testing

Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)

Who this might be right for
Retinal TelangiectasisIdiopathic Juxtafoveal Retinal Telangiectasia
ThromboGenics 8
Testing effectiveness (Phase 2)Study completedNCT02302989
What this trial is testing

Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Leonard Feiner, MD, PhD 4
Not applicableStudy completedNCT04723160
What this trial is testing

Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph

Who this might be right for
Diabetic RetinopathyRetinal Vein OcclusionRetinal Artery Occlusion+10 more
Visionary Intelligence Ltd. 748
Large-scale testing (Phase 3)WithdrawnNCT00557791
What this trial is testing

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)

Who this might be right for
Age Related Macular Degeneration
OPKO Health, Inc.
Testing effectiveness (Phase 2)Study completedNCT00992563
What this trial is testing

WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment Examination

Who this might be right for
Age Related Macular Degeneration
Alcon Research 35
Post-approval studies (Phase 4)Study completedNCT02060604
What this trial is testing

Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Università degli Studi di Brescia 60
Not applicableStudy completedNCT03712670
What this trial is testing

Nutraceutical Support With Omega-3

Who this might be right for
Retinal Disease
Università degli Studi di Brescia 60
Not applicableEnded earlyNCT02625376
What this trial is testing

Resveratrol for Exudative Age-Related Macular Degeneration

Who this might be right for
AMDAge-related Macular DegenerationChoroidal Neovascularisation
Poitiers University Hospital 25
Large-scale testing (Phase 3)Study completedNCT00058994
What this trial is testing

An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD

Who this might be right for
Macular DegenerationMaculopathy, Age-Related
Alcon Research
Load More Results